tradingkey.logo
搜尋

Treace Medical Concepts Inc

TMCI
添加自選
4.210USD
-0.020-0.47%
收盤 07/02, 13:00美東報價延遲15分鐘
272.75M總市值
虧損本益比TTM

Treace Medical Concepts Inc

4.210
-0.020-0.47%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.47%

5天

-5.61%

1月

+14.09%

6月

+68.40%

今年開始到現在

+71.84%

1年

-31.88%

關鍵數據
4.290今開
4.425最高
460.66K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.71%換手率
4.230昨收
4.105最低
1.36M成交額
虧損本益比靜
3.53市淨率
0.00%股息率 TTM
-31.31%ROA
7.78052週最高
0.38量比
-55.74M淨利潤
64.79M總股本
-0.9565每股盈餘TTM
1.29Beta
-66.88%ROE
1.17052週最低
7.57%振幅
79.26%毛利率
272.75M總市值
2.90回報/風險
5.04%風險率

TradingKey Treace Medical Concepts Inc股票評分

單位: USD 更新時間: 2026-07-02

操作建議

Treace Medical Concepts Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名118/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為4.00。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Treace Medical Concepts Inc評分

相關信息

行業排名
118 / 204
全市場排名
283 / 4565
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Treace Medical Concepts Inc亮點

亮點風險
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入212.69M美元
估值高估
公司最新PE估值-4.40,處於3年歷史高位
機構減倉
最新機構持股37.97M股,環比減少29.23%
活躍度增加
近期活躍度增加,過去20天平均換手率0.99

分析師目標

基於 5 分析師
持有
評級
4.000
目標均價
-5.44%
漲幅空間

Treace Medical Concepts Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Treace Medical Concepts Inc簡介

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
公司代碼TMCI
公司Treace Medical Concepts Inc
CEOTreace (John T)
網址https://www.treace.com/

常見問題

Treace Medical Concepts Inc(TMCI)的當前股價是多少?

Treace Medical Concepts Inc(TMCI)的當前股價是 4.21。

Treace Medical Concepts Inc 的股票代碼是什麼?

Treace Medical Concepts Inc的股票代碼是TMCI。

Treace Medical Concepts Inc股票的52週最高點是多少?

Treace Medical Concepts Inc股票的52週最高點是7.78。

Treace Medical Concepts Inc股票的52週最低點是多少?

Treace Medical Concepts Inc股票的52週最低點是1.17。

Treace Medical Concepts Inc的市值是多少?

Treace Medical Concepts Inc的市值是272.75M。

現在Treace Medical Concepts Inc(TMCI)的股票是買入、持有還是賣出?

根據分析師評級,Treace Medical Concepts Inc(TMCI)的總體評級為signal_hold,目標價格為4.00。

Treace Medical Concepts Inc(TMCI)股票的每股收益(EPS TTM)是多少

Treace Medical Concepts Inc(TMCI)股票的每股收益(EPS TTM)是-0.93。